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Oxygen (O2) is life essential but as a drug has a maximum positive biological beneﬁt and accompanying toxicity eﬀects. Oxygen
is therapeutic for treatment of hypoxemia and hypoxia associated with many pathological processes. Pathophysiologicalprocesses
are associated with increased levels of hyperoxia-induced reactive O2 species (ROS) which may readily react with surrounding
biological tissues, damaging lipids, proteins, and nucleic acids. Protective antioxidant defenses can become overwhelmed with
ROS leading to oxidative stress. Activated alveolar capillary endothelium is characterized by increased adhesiveness causing
accumulation ofcell populations such as neutrophils,which are a source of ROS. Increased levels of ROS cause hyperpermeability,
coagulopathy, and collagen deposition as well as other irreversible changes occurring within the alveolar space. In hyperoxia,
multiple signaling pathways determine the pulmonary cellular response: apoptosis, necrosis, or repair. Understanding the eﬀects
of O2 administration is important to prevent inadvertent alveolar damage caused by hyperoxia in patients requiring supplemental
oxygenation.
1.Introduction
When administering supplemental oxygen(O2)t ot r e a th yp -
oxemiaassociatedwithacuteandchronicconditions,O2 tox-
icity by overexposure may be present. Annually, the need for
supplemental O2 is projected to be around 800,000 individ-
uals at a cost of 1.8 billion dollars [1]. Suboptimal use of O2
is reﬂected in prescription and treatment errors that exceed
those related to antibiotics [2–4].
The alveolar epithelial and alveolar capillary endothelial
cellsar evulnerabletargetsforO 2-free-radical-induced injury
caused by hyperoxia. In acute lung injury (ALI) caused by
hyperoxia, hyperpermeability ofthe pulmonary microvascu-
lature causes ﬂooding of the alveolus with plasma extravasa-
tions leading to pulmonary edema and abnormalities in the
coagulation and ﬁbrinolysis pathways promoting ﬁbrin de-
position [5, 6]. Type II alveolar epithelial cells are injured by
O2 free radicals leading to impairment of surfactant pro-
duction [7]. Thus, the maximum positive biological beneﬁt
for this life essential but toxic molecule exists along a dose-
response, deﬁciency–toxicity continuum.
2.PathophysiologyofOxygenToxicity
Hyperoxia is a state of excess supply of O2 in tissues and
organs. Oxygen toxicity occurs when the partial pressure of
alveolar O2 (PAO2) exceeds that which is breathed under
normal conditions. With continuous exposure to supraphys-
iologic concentrations of O2, a state of hyperoxia develops.
Under hyperoxic pathological conditions, a large inﬂux of
reactive O2 species (ROS) are produced. In intracellular and
extracellular biological systems, the mass eﬀect of ROS ele-
vation, caused by O2 overexposure, disrupts the balance be-
tween oxidants and antioxidants, and this disruption of ho-
meostasis can result in damage to cells and tissues [8–11].
Exposure time, atmospheric pressure, and fraction of in-
spired O2 (FIO2) determine the cumulative O2 dose leading2 Nursing Research and Practice
to toxicity. Oxygen is toxic to the lungs when high FIO2
(>0.60) is administered over extended exposure time (≥24
hours) at normal barometric pressure (1 atmospheres abso-
lute (ATA)). This type of exposure is referred to as low
pressure O2 poisoning, pulmonary toxicity, or the Lorraine
Smith eﬀect. Oxygen exposure after approximately 12 hours
leads to lung passageway congestion, pulmonary edema, and
atelectasis caused by damage to the linings of the bronchi
and alveoli. The formation of ﬂuid in the lungs causes a
feeling of shortness of breath combined with a burning of
the throat and chest, and breathing becomes very painful
[12]. The reason for this eﬀect in the lungs but not in other
tissues is that the air spaces of the lungs are directly exposed
tothehighO2 pressure.Oxygenisdeliveredtotheotherbody
tissuesat almost normal partial pressureofO2 (PO2)because
of the hemoglobin-O2 buﬀer system [13–15]. Toxicity also
occurs when the ATA is high (1.6–4) and the high FIO2
exposure time is short. This type of exposure is referred to
as high pressure O2 poisoning or the Paul Bert eﬀect and is
toxic to the central nervous system (CNS). Central nervous
system toxicity results in seizures followed by coma in most
people within 30 to 60 minutes. Seizures oftenoccur without
warning and are likely to be lethal. Other symptoms include
nausea, muscle twitching, dizziness, disturbances of vision,
irritability,anddisorientation[13,16–20].Oceanicdiversare
more likely to experience CNS toxicity [17].
Pulmonary capillary endothelial and alveolar epithelial
cells are targets for ROS resulting in injury-induced lung
edema, alveolar ﬂooding, hemorrhage, and collagen, elastin,
and hyaline membrane deposits [11, 21, 22]. Above a critical
PAO2,thehemoglobin-O2 buﬀeringmechanism fails and the
tissue PO2 can rise to hundreds or thousands of mmHg. At
high levelsof O2, protective endogenous antioxidant enzyme
systems become consumed by ROS leading to cell death [16,
23].
Oxygentoxicitycaused byROSprogresses in overlapping
phases based on degree of severity and reversibility of injury.
The phases are initiation, inﬂammation, proliferation, and
ﬁbrosis. Initially, there are increased ROS and depleted
antioxidant levels, and the lung fails to clearitself of mucous.
The inﬂammation phase or exudative phase is characterized
by the destruction of the pulmonary lining and migration
of leukocyte derived inﬂammatory mediators to the sites
of injury. The proliferative phase is subacute and there are
cellular hypertrophy, increased secretions from surfactant
secreting alveolar type II cells, and increased monocytes. The
ﬁnal terminalphaseis theﬁbrotic phasein which thechanges
to the lung are irreversible and permanent. There is collagen
depositionand thickeningofthepulmonary interstitialspace
and the lung becomes ﬁbrotic [24–27].
Clinically, progressive hypoxemia, or high O2 tension in
the blood, requires increased FIO2 and assisted ventilation,
whichfurtheraggravatethepathophysiologicalchangesasso-
ciated with O2 toxicity. Chest X-rays may show an alveolar
interstitial pattern in an irregular distribution with evidence
of a moderate loss of volume from atelectasis, however there
is no clinical way of diagnosing O2 toxicity. Lung biopsy
specimens may show changes consistent with O2 toxicity but
the primary value of the biopsy is to exclude other causes of
lung injury. Air pressure changes within the enclosed lung
cavity and ventilator-induced injury may accompany and be
indistinguishable from O2 toxicity. Oxygen toxicity can be
minimized by keeping the PAO2 less than 80mm Hg or the
FIO2 below 0.40 to 0.50 [12].
The pulmonary cellular response to hyperoxic exposure
and increased ROS is well described. Anatomically, the pul-
monary epithelial surface is vulnerable to a destructive in-
ﬂammatory response. This inﬂammation damages the alve-
olar capillary barrier leading to impaired gas exchange and
pulmonary edema. Reactive O2 species induces pulmonary
cell secretion of chemoattractants, and cytokines stimulate
macrophage and monocyte mobilization and accumulation
into thelungs, leading toadditionalROS.The ROSleukocyte
interaction further exacerbates injury. Research has shown
that as these highly reduced cell layers become increasingly
oxidized and levels of antioxidants fall, ROS-induced acti-
vation of multiple upstream signal transduction pathways
regulates the cellular response: adaptation, repair, or cell
death by apoptosis, oncosis, or necrosis [28, 29].
Mitogen-activated protein kinase (MAPK), toll-like re-
ceptor 4 (TLR4), signal transducers and activators of tran-
scription(STAT),andnuclearfactorkappabeta(NFkβ)ar ea
few well-researched protein pathways that communicate the
receptor signal to the deoxyribonucleic acid (DNA) of the
cell thereby determining the cellular response. The MAPK
pathway is a regulator of cell death genes, stress, and trans-
formation and growth regulation. Mitogen-activated protein
kinase activation precedes extracellular signal regulated
kinase (ERK1/2), a promoter of cell proliferation. C-Jun-
terminal protein kinase (JNK1/2) and p38 kinase both
induce cell death and inﬂammation [30]. The TLR4, STAT,
and nuclear regulatory factor 2 (Nrf2) pathways are associ-
ated with survival gene expression such as caspase-3 proteins
and antioxidant response element (ARE) [31, 32]. The NF
kβ pathway is an up-stream signal for inﬂammation and sur-
vival genes: anti-oxidant enzymes (AOE), Bcl-2, AKT, heme
oxygenase (HO-1), and heat shock proteins (HSPs). The
AKT1−4 family of signals plays an important role in glucose
metabolism, cell proliferation, apoptosis, transcription, and
cell migration. The Bcl-2 proteins are antiapoptotic while
HO-1andHSPsareubiquitousstress-response proteins[33].
These signaling pathways are regulators of the pulmonary
epithelial cell response to increases in ROS and hyper-
oxia [18, 34]. Cytokine and chemokine overexpression in
response to hyperoxic stress can be protective. Tumor necro-
sis factor alpha (TNFα), interleukin 1 beta (IL-1β), interleu-
kin 6 (IL-6), chemokine receptor 2 (CXCR2), interleukin 11
(IL-11), insulin and keratinocyte growth factor expression,
and the beta subunit of Na, K-ATPase have been shown to
attenuate death signals [35–37].
3.The FormationofFree Radicals
Oxygen is a requirement for cellular respiration in the me-
tabolism of glucose and the majority of O2 consumed by the
mitochondria is utilized for adenosine triphosphate (ATP)
generation [38, 39]. The mitochondrial electron transportNursing Research and Practice 3
chain reduces the elemental molecular O2 to ionic O2 by the
relay of electrons making O2 usable for ATP generation, dur-
ingthisprocess,oxidizingfreeradicals aregenerated[40,41].
Toxic levels of O2 lead to the formation of additional ROS,
which can impose damage to lipid membranes, proteins, and
nucleic acids. Reactive O2 species mediate physiological and
pathophysiological roles within the body [42].
Free radicals are a type of unstable, reactive, short-lived
chemical species that have one or more unpaired electrons
and may possess a net charge or be neutral. The species is
termed free because the unpaired electron in the outer orbit
is free to interact with surrounding molecules [42, 43]. Cells
generate free radicals, or ROS, by the reduction of molecular
O2 to water (H2O) (Figure 1)[ 44, 45].
Chemically,threetypesofreactions leadtotheformation
of ROS. The one-electron reduction of molecular O2 to the
superoxide anion (O2
−•) is catalyzed by transition metals
including iron (Fe) and copper (Cu) such as
FeII +O 2 −→ FeIII +O 2
−•. (1)
The simultaneous oxidation reduction reaction of O2
−•
tohydrogen peroxide(H2O2) and the additionofanelectron
to O2
−• produce the hydroxyl radical (HO•). The O2
−•
in biological membranes can act in four diﬀerent modes:
electron transfer, nucleophilic substitution, deprotonation,
and a hydrogen atom abstraction as in
O2
−• +O 2
−• +2 H + −→ H2O2 +O 2. (2)
AO 2
−• initiated Fenton-typereaction and the decompo-
sition of H2O2 requires O2
−• and H2O2 as precursors and Fe
a n dC up r e s e n c ef o rc o m p l e t i o n .T h eH O • is the most injury
producing in biological systems, reacting with molecules
in close proximity. These reactions are called Fenton-like
reactions generating O2 and HO• when FeII or CuI reacts
with H2O2
FeIII +O 2
−• −→ FeII +O 2 (3)
FeII +H 2O2 −→ FeIII +HO
• +HO
• (4)
O2
−• +H 2O2 −→ O2 +HO
• +H O
•. (5)
The sum of reactions (3)a n d( 4), or the Haber-Weiss
reaction shown in (5)abo v edem on s trat esHO • formationby
the metal-catalyzed decomposition of H2O2. The interaction
between O2
−• and H2O2 is the source of the majority of
damage to biological systems due to the reactivity of contin-
uously produced, highly toxic HO• [18, 46, 47]. These ROS-
producing reactions occur endogenously involving enzymes,
neutrophils, and organelles such as the mitochondria and
exogenously induced by radiation, pollutants, xenobiotics,
and toxins. Cellular survival and adaptation in an oxida-
tive atmosphere are dependent upon suﬃcient antioxidant
defenses to counteract the eﬀects of ROS on cells and tissues
[48].
e− e− +2H + e− +H + e− +H +
Oxygen Superoxide
anion
Hydrogen
peroxide
Hydroxyl
radical
Water
O2 O −•
2 H2O2 HO− H2O
Figure 1: Reduction of oxygen. A single-electron transfer which
converts molecular oxygen to the superoxide anion,creating an un-
stable molecule. The decomposition of hydrogen peroxide can be
a source of the hydroxyl radical; this reaction requires both super-
oxide and hydrogen peroxide as precursors. These steps reduce oxy-
gentowaterbytheadditionoffourelectrons, yielding three reactive
oxygen species: superoxide anion, hydrogen peroxide, and hydroxyl
radical.
4.Functionsand Classiﬁcationsof Antioxidants
Oxidant antioxidant homeostasis is highly regulated and
essential for maintaining cellular and biochemical functions
[49]. A change in the balance toward an increase in the ox-
idant over the capacity of the antioxidant deﬁnes oxidative
stress and can lead to oxidative damage. Changing the bal-
ance toward an increase in the reducing power of the anti-
oxidant can also cause damage and is deﬁned as reductive
stress [50–52].Reduction,antioxidant andoxidation,orpro-
oxidant reactions result from a gain or a loss of electrons and
a loss or a gain in O2 [50, 53, 54].
An antioxidant (a reductant or reducing agent) is any-
thing that can prevent or inhibit oxidation [55–57]. Delay
of oxidation can be achieved by preventing the generation
or inactivating ROS [58]. Prevention, diversion, dismutation
(decay), scavenging, and quenching are specialized antiox-
idant properties (Table 1). Antioxidant defenses may be
classiﬁedasnonenzymaticandenzymaticorendogenousand
dietary. Examplesofnonenzymaticantioxidants areglutathi-
one (GSH), ascorbic acid, vitamin E, beta-carotene, and uric
acid.Majorenzymatic antioxidantsaresuperoxidedismutase
(SOD), catalase, and GSH peroxidase which divert or dis-
mutate ROS into harmless products. Endogenous or dietary
antioxidants are based on the ability of the antioxidant to be
synthesized by humans. Endogenous antioxidants are SOD,
catalase, GSH peroxidase, uric acid, and bilirubin. Dietary
antioxidants are ascorbic acid, vitamin E, and beta-carotene
[59, 60]. Ascorbic acid, vitamin E, uric acid, bilirubin, and
GSH scavenge ROS by expendable, replaceable, or recyclable
substrates. Vitamin E and beta-carotene quench ROS by
absorption of electrons and/or energy.
Antioxidants can be classiﬁed into four categories based
on function. (1) Preventive antioxidants which suppress for-
mation of ROS, (2) radical scavenging antioxidants which
suppress chain initiation and/or break chain propagation
reactions, (3) the repair and de novo antioxidants such as
proteolytic enzymes and the repair enzymes of DNA, and
(4)antioxidants which allowforadaptationthatoccurswhen4 Nursing Research and Practice
Table 1: Locations and properties of antioxidants.
Enzymatic antioxidants located in mitochondria and cytosol
Glutathione peroxidase (GSH) Removal of H2O2, hydroperoxides
Superoxide dismutase (SOD) Catalytic removal of O2
Catalase (CAT) Catalytic reduction of H2O2 to H2O
Nonenzymatic antioxidants located in cell membrane, exogenous dietary source
Vitamin E (α tocopherol) Chain-breaking antioxidant
β-carotene Scavenger of ROS, singlet O2 quencher
Co-enzyme Q Regenerates vitamin E
Compounds that reduce the availability of transition metals, Fenton reactions
Transferrin Sequesters iron and copper ions
Lactoferrin Sequesters iron at lower pH
Albumin Sequesters heme and copper
Ceruloplasmin (ferroxidase) Scavenges superoxide radical, binds copper ions
Scavengers, products of metabolism, exogenous dietary source
Bilirubin Scavenges peroxyl radical
Uric acid Scavenges hydroxyl radical
Vitamin C (ascorbic acid) Scavenges hydroxyl radical, recycles vitamin E
Thiol group donors
Reduced glutathione (GSSH) Binds free radicals, SH group oxidized to disulﬁde group (GSSG)
α-lipoic acid Recycles vitamin C, glutathione substitute
the signal for the production and reactions of ROS induces
oxidant formation and transport [10, 61].
Superoxide dismutase converts O2
•− to H2O2 and has
three isoforms widely distributed in mammalian organisms.
(1) Cytoplasmic SOD (SOD1 or Cu zinc (CuZn) SOD) is
located in the cytoplasm, nucleus, and peroxisomes, (2) mi-
tochondrial SOD (SOD2 or MnSOD) is located in the mito-
chondrial matrix near the electron transport chain, and (3)
extracellular SOD (SOD3 or EcSOD) is found in the extra-
cellular ﬂuids and extracellular matrix of all human tissues
especially the heart, placenta, pancreas, and lung [62–64].
The protective eﬀects of EcSOD in the lungs are extremely
important and well-established [65–68].
Catalase, one of the most potent catalysts found mostly
in the peroxisome, functions to decompose H2O2 to H2O.
Catalase defense from oxidant injury to lung epithelial cells
exists in the cytosol or the mitochondria.
Glutathione reductase is an important antioxidant en-
zyme for maintaining the intracellular reducing environ-
ment. This enzyme catalyzes the reduction of glutathione
disulﬁde (GSSG) to GSH [69]. Glutathione disulﬁde is pro-
duced through the oxidation of GSH by ROS that arise
during conditions of oxidative stress. Due to the high con-
centrations of GSH, GSH/GSSG is considered to be the
principal redox buﬀer of the cell and the ratio of GSH/GSSG
is viewed as a major indicator of the cellular redox status.
The ratio of GSH/GSSG decreases under an oxidative stress
condition [70, 71]. Tissue damage may develop when an
oxidant/antioxidant imbalance occurs as a consequence of
hyperoxia [72, 73]. The damaging eﬀects of hyperoxia can
lead to O2 toxicity, cell death, and can be a triggering factor
in ALI [22].
5.ClinicalPresentationofHyperoxicAcute
LungInjury
Acute lung injury and acute respiratory distress syndrome
(ARDS)are secondarily occurring, inﬂammatory syndromes
caused by triggers or risk factors described as direct or
indirect, pulmonary or extrapulmonary. The pathological
changes associated with HALI mimic the ALI triggered by
other conditions such as hemorrhagic shock, reperfusion
injury, pneumonia, sepsis, or paraquat inhalation [23, 33,
74, 75]. The risk of developing ALI or ARDS after inhalation
injury is dependent on the toxicity and concentration of the
inhaled substance [17]. For example, the cells and structure
of the alveolar capillary membrane are highly susceptible
to damage by toxic levels of O2 [76]. Both ALI and ARDS
are the same clinical disorder, diﬀering only in severity of
hypoxemia. The ratio between arterial pressure of O2 (PaO2)
and the FIO2 concentration delivered by ventilator support
distinguishes the two syndromes. For ALI, the PaO2/FIO2 is
≤300mmHg and for ARDS, the PaO2/FIO2 is ≤200mmHg
[74, 75, 77].
The injury to the alveolus is thought to develop when
pulmonary or systemic inﬂammation leads to systemic re-
lease of cytokines and other proinﬂammatory molecules.
Mast cells, which express mediators that exert eﬀects on lung
vasculature, are also increased after hyperoxic exposure
[78]. Cytokine release activates alveolar macrophages and
recruits neutrophils to the lungs. Subsequent activation of
leukotrienes,oxidants,plateletactivating factor, and protease
occurs. These substances damage capillary endothelium and
alveolar epithelium, disrupting the barriers between the cap-
illaries and air spaces. Edema ﬂuid, proteins, and cellularNursing Research and Practice 5
debris ﬂood the air spaces and interstitium, causing disrup-
tion of surfactant, airspace collapse, ventilation-perfusion
mismatch, shunting, and stiﬀening of the lungs with de-
creased compliance and pulmonary hypertension. There is
no pattern to the injury; however, dependant lung areas are
most frequently aﬀected [74, 79].
Tissue examination reveals that surfactant disruption,
epithelial injury, and sepsis initiate the increased expression
of cytokines that sequester and activate inﬂammatory cells.
Increased release of ROS alters normal endothelial function.
Microarray analysis has revealed increased expression of
genesrelatedtooxidativestress, antiproteolyticfunction,and
extracellular matrix repair as well as decreased surfactant
proteins in ozone-inducedALI [80]. Diﬀuse alveolar damage
results with intra-alveolar neutrophils indicating the pres-
ence of an inﬂammatory response in the alveoli. Red blood
cells, cellular fragments, and eroded epithelial basement
membranes are present with formation of hyaline mem-
branes, indicating that serum proteins have entered and
precipitatedin theair spacesdueto disruptionofthealveolar
capillary barrier. Formation of microthrombi indicates the
presence of endothelial injury and activation of the coagula-
tion cascade [81].
Acute lung injury syndrome presents within 24 to 48
hours after the direct or indirect trigger. Initially, the patient
may experience dyspnea, cough, chest pain, tachypnea, ta-
chycardia, accessory muscle use, cyanosis, mottled skin, and
abnormal breath sounds (crackles, rhonchi, and wheezing).
Blood gas analysis reveals progressive worsening of hypox-
emia, leading to respiratory failure. Bilateral inﬁltrates are
seen on a chest X-ray and are consistent with pulmonary
edema but without the cardiac component of elevated left
atrial pressure. Treatment includes mechanical ventilation,
supportivecare, and treatment oftheunderlying causes[16].
The mortality of ALI has improved over the past decade;
however, it still ranges from 30% to 75% [75, 77, 82, 83]a n d
occurs in about 86 of 100,000 individuals per year [84].
6.Conclusion
Oxygen, often used to treat hypoxemia in the clinical setting,
is itself a triggering factor in HALI given that the exposure is
suﬃciently concentrated and of adequate duration. The lung
is a vulnerable target for oxidant-induced injury, initiating
a cascade of protein signals that determine the cellular re-
sponse. The alveolar epithelial and alveolar capillary endo-
thelial surfaces are injured. Hyperpermeability, microthrom-
bi (resulting from altered coagulation and ﬁbrinolysis),
collagen deposition, and ﬁbrosis alter alveolar structure
and function. Understanding precise mechanisms of injury
and pulmonary cellular responses to hyperoxia is essential
evidence for expert practice.
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